ICOC/Governing Board

 

MEETING NOTICE AND AGENDA
REGULAR MEETING OF THE
INDEPENDENT CITIZENS’ OVERSIGHT COMMITTEE
CALIFORNIA INSTITUTE FOR REGENERATIVE MEDICINE
Organized Pursuant To The
CALIFORNIA STEM CELL RESEARCH AND CURES ACT

Date:
Wednesday, September 5th, 4:00 pm – 9:00 pm

and

Thursday, September 6th, 9:00 am – 5:00 pm

Main Location:
Crowne Plaza Hotel
1177 Airport Blvd.
Burlingame, CA 94010

Other Locations:

2121 Avenue of the Stars, Suite 2020
Los Angeles, CA 90067

5575 W Las Positas Blvd
Pleasanton, CA

CONNECT -  Wednesday Only
8950 Villa La Jolla Drive Suite A-124
La Jolla, CA 92037

1500 E. Duarte Road - Thursday only
Duarte, CA 91010

[Members of the Public will be invited to provide testimony before or during
consideration of each item. Makers of public comments are asked to limit their testimony
to three (3) minutes.]

Audiocast:

General Public have two choices to listen to the meeting, telephone or Internet streaming.

Sept 5- Dial In: (800) 260-0702; Access: 258964

To access the live event or archive, use this URL:
https://im.csgsystems.com/cgi-bin/confCast

Enter Conference ID# 258964
Then click Go.

Sept 6- Dial In: (866) 233-3842; Access: 258965

To access the live event or archive, use this URL:
https://im.csgsystems.com/cgi-bin/confCast

Enter Conference ID# 258965
Then click Go.

In addition, the meeting will be recorded and available on demand for one month following the meeting.

REPORTS & DISCUSSION ITEMS

1. Call to Order.
2. Pledge of Allegiance.
3. Roll Call.
4. Chairman’s Report.
5. President's Report, including but not limited to update regarding CIRM’s response to Performance Audit recommendations.
A. Contracts summary

ACTION ITEMS

6. Consideration of appointment of new Scientific members of the Grants Working Group.
7. Consideration of amendments to the Grants Administration Policy.
8. Consideration of applications for Disease Team Therapy Development Awards (RFA 10-05).
Extraordinary petition DR2A-05410
Additional correspondence DR2A-05373
Recommendations from additional analysis
Presentation

CLOSED SESSION

9. Discussion of confidential intellectual property or work product, prepublication data, financial information, confidential scientific research or data, and other proprietary information relating to applications for Disease Team Therapy Development Awards (RFA 10-05), applications for Research Leadership Awards (RFA 09-04), and applications for Basic Biology IV Awards (RFA 11-03). (Health & Safety Code 125290.30(f) (3) (B) and (C)). 

ACTION ITEMS

10. Consideration of application for Research Leadership Awards (RFA 09-04). 
Presentation
11. Consideration of items from the Science Subcommittee, including: Science Subcommittee Mission Statement,,
External Bolt-On Funding Proposal
12. Consideration of applications for Basic Biology IV Awards (RFA 11-03)
Presentation
Extraordinary petition RB4-05746
Extraordinary petition RB4-05764 
Extraordinary petition RB4-06239
Extraordinary petition RB4-06256
Extraordinary petition RB4-05816
Extraordinary petition RB4-06117
Extraordinary petition RB4-06277

13. Consideration of minutes from theMay 2012  and July 2012  board meetings.

DISCUSSION ITEM

14. Spotlight on Disease.

ACTION ITEMS

15. Consideration of proposed amendments to the Intellectual Property Regulations, including but not limited to revenue sharing prov
A. Memo
B. 100600 amendments
C. 100601 amendments
D. 100602 amendments
E. 100608 amendments
Presentation

16. Consideration of modifications to the Extraordinary Petition policy  and adoption of Additional Information Policy..
Presentation

DISCUSSION ITEM

17. Communications Update..

ACTION ITEMS

18. Consideration of a resolution honoring Ted Love.
19. Consideration of amendments to the Strategic Partnership Funding concept plan
Presentation
20. Consideration of Adoption of Amendments to Medical and Ethical Standards, Regulations 100060 and 100070.
Presentation

Proposed additional agenda item

THE ORDER OF BUSINESS MAY BE CHANGED WITHOUT NOTICE.

**NOTICE**

The California Institute for Regenerative Medicine and its Independent Citizens Oversight Committee, and any subcommittees thereof, comply with the Americans with Disabilities Act (ADA) by ensuring that the meeting facilities are accessible to persons with disabilities, and providing that this notice and information given to the Members of the Committee is available to the public in appropriate alternative formats when requested. If you need further assistance, including disability-related modifications or accommodations, you may contact Maria Bonneville at the California Institute for Regenerative Medicine at 415-396-9100 no later than the day prior to the meeting.

Questions or requests for additional information prior to the Independent Citizens Oversight Committee meeting may be referred to Maria Bonneville at the California Institute for Regenerative Medicine at mbonneville@cirm.ca.gov or 415-396-9100.

Transcripts: 

© 2013 California Institute for Regenerative Medicine